2016
DOI: 10.1097/mlr.0000000000000502
|View full text |Cite
|
Sign up to set email alerts
|

Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert

Abstract: Background-Responsiveness to the Food and Drug Administration (FDA) rosiglitazone safety alert, issued on May 21, 2007, has not been examined among vulnerable subpopulations of the elderly.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 25 publications
0
9
0
Order By: Relevance
“…All of the 70 publications included are observational studies based on routinely collected health data, which included health insurance or hospital records. Thus, no RCTs were found for the defined search period.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…All of the 70 publications included are observational studies based on routinely collected health data, which included health insurance or hospital records. Thus, no RCTs were found for the defined search period.…”
Section: Resultsmentioning
confidence: 99%
“…Unintended effects of a safety warning were examined in six out of 72 studies . These six studies could not be analysed regarding the effectiveness of safety warnings, because an unintended effect occurred in connection with a safety warning, but not as a direct consequence of the content.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations